MiR-34a acts as a tumor suppressor miR by down-regulating its target genes such as BCL-2 and SIRT1 [145] and Notch1 [146], Wnt/β-catenin signaling pathway [147], fra-1 [148] and MYC [149]. Here, BCL2 is linked to neoplasm.